CXCR4 signaling in health and disease
Tommaso Pozzobon1, Giacomo Goldoni2, Antonella Viola1
1Department of Biomedical Sciences, University of Padua, Padua, Italy; Venetian Institute of Molecular Medicine (VIMM), Padova, Italy.
Abstract:
Chemokines and chemokine receptors regulate multiple processes such morphogenesis, angiogenesis and immune responses. Among the chemokine receptors, CXCR4 stands out for its pleiotropic roles as well as for its involvement in several pathological conditions, including immune diseases, viral infections and cancer. For these reasons, CXCR4 represents a crucial target in drug development. In this review, we discuss of CXCR4 receptor properties and signaling in health and diseases, focusing on the WHIM syndrome, an inherited immunodeficiency caused by mutations of the CXCR4 gene.
Insights
Chemokine receptor CXCR4 has diverse roles in health and disease, making it a key drug development target. Mutations in CXCR4 cause WHIM syndrome, an inherited immunodeficiency.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Chemokines and their receptors orchestrate critical cellular processes, including morphogenesis, angiogenesis, and immune responses.
- The chemokine receptor CXCR4 exhibits pleiotropic functions and is implicated in various pathologies such as immune disorders, viral infections, and cancer.
- CXCR4's multifaceted roles establish it as a significant target for therapeutic interventions.
Purpose of the Study:
- To review the properties and signaling pathways of the CXCR4 receptor in both physiological and pathological contexts.
- To highlight the specific involvement of CXCR4 in WHIM syndrome, an inherited immunodeficiency.
- To underscore CXCR4's importance as a drug development target.
Main Methods:
- Literature review of scientific publications on CXCR4.
- Analysis of CXCR4's role in cellular processes and disease pathogenesis.
- Focus on genetic mutations leading to WHIM syndrome.
Main Results:
- CXCR4 is essential for normal biological functions and its dysregulation contributes to disease.
- Mutations in the CXCR4 gene are the underlying cause of WHIM syndrome, characterized by immunodeficiency.
- Understanding CXCR4 signaling provides insights into therapeutic strategies for various conditions.
Conclusions:
- CXCR4 is a pivotal molecule in immunity and disease, necessitating further research for therapeutic applications.
- Targeting CXCR4 offers potential for treating conditions ranging from viral infections to cancers and immunodeficiencies like WHIM syndrome.
- This review consolidates current knowledge on CXCR4, emphasizing its therapeutic relevance.
More Related Videos
Related Concept Videos
Canonical Wnt Signaling Pathway
The JAK-STAT Signaling Pathway
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Hedgehog Signaling Pathway


